<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48668">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02014428</url>
  </required_header>
  <id_info>
    <org_study_id>HA-123</org_study_id>
    <nct_id>NCT02014428</nct_id>
  </id_info>
  <brief_title>Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGUNCO Obstetrics and Gynecology Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AGUNCO Obstetrics and Gynecology Centre</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the
      treatment of atrophic vaginitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>Atrophic vaginal changes</measure>
    <time_frame>Change from baseline epithelium at 3 months</time_frame>
    <description>Morphometric analysis of biopsies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Itching</measure>
    <time_frame>Change from baseline Itching at 3 months</time_frame>
    <description>Scale: absent, mild, moderate, severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Burning</measure>
    <time_frame>Change from baseline Burning at 3 months</time_frame>
    <description>Scale: absent, mild, moderate, severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Dyspareunia</measure>
    <time_frame>Change from baseline Dyspareunia at 3 months</time_frame>
    <description>Scale: absent, mild, moderate, severe.</description>
  </secondary_outcome>
  <condition>Atrophic Vaginitis</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>220 mg hyaluronic acid per tablet (two tablets/day for 10 days, and subsequently one tablet/day for three months)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>two tablets/day for 10 days, and subsequently one tablet/day for three months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <arm_group_label>Hyaluronic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 12 months postmenopausal

          -  mucosal atrophy and the main bothersome related symptoms, such as itching, burning,
             and dyspareunia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Department of Gynecological, Obstetric Sciences and Reproductive Medicine, University of Messina.</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 12, 2013</lastchanged_date>
  <firstreceived_date>December 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaginitis</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
